Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
3
×
san diego blog main
san francisco blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
gene therapy
indiana blog main
indiana top stories
ipo
messenger rna
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
approval
apremilast
What
ipo
3
×
therapeutics
3
×
biotechs
million
new
ago
allogene
bio
cancer
club
companies
considering
continued
crispr
crop
data
diseases
diversity
drug
dyne
early
exceeded
expected
experimental
eyes
firms
genetic
group
haul
having
hot
humans
immunotherapy
investors
ipos
joined
juno
latest
life
long
Language
unset
Current search:
therapeutics
×
ipo
×
" new york blog main "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M